Predicted protein targets (top 2)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CCKBR | P32239 | 9/20 | 0.67 |
| ▸ | CXCL8 | P10145 | 10/20 | 0.62 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29362913 | 1.00 | CCKBR (0.67) | CCKBRCXCL8 | |
| SCHEMBL23928719 | 1.00 | CCKBR (0.67) | CCKBRCXCL8 | |
| SCHEMBL29150398 | 0.97 | CCKBR (0.62) | CCKBRCXCL8 | |
| SCHEMBL30339999 | 0.95 | CXCL8 (0.60) | CCKBRCXCL8 | |
| SCHEMBL30435302 | 0.94 | CXCL8 (0.60) | CCKBRCXCL8 | |
| SCHEMBL29360635 | 0.90 | CCKBR (0.57) | CCKBRCXCL8 | |
| SCHEMBL11566228 | 0.88 | PTGS1 (0.56) | CCKBRCXCL8 | |
| SCHEMBL29369719 | 0.87 | CXCL8 (0.69) | CCKBRCXCL8 | |
| SCHEMBL30435375 | 0.86 | CXCL8 (0.65) | CCKBRCXCL8 | |
| SCHEMBL29408673 | 0.86 | CCKBR (0.70) | CCKBR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 6908 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4747356-A1 | CO-CULTURES OF ORGANOIDS AND STROMAL CELLS | HUB Organoids IP B.V. (NL) | 2026-05-27 | — | — | EP | claimed |
| CN-122081231-A | Culture medium and culture method for small intestine tumor organoids | — | 2026-05-26 | — | — | CN | claimed |
| WO-2026106127-A1 | LACTICASEIBACILLUS PARACASEI HP7 USEFUL FOR GASTROINTESTINAL HEALTH WITH PREVENTIVE OR ALLEVIATIVE EFFICACY FOR FUNCTIONAL DYSPEPSIA AND USES THEREOF | 주식회사 에치와이 | 2026-05-21 | — | — | WO | claimed |
| EP-3729084-B1 | IMMUNE CELL ORGANOID CO-CULTURES | KONINKLIJKE NEDERLANDSE AKADEMIE VAN WETENSCHAPPEN (NL) | 2026-05-20 | — | — | EP | claimed |
| WO-2026102462-A1 | ENGINEERED CELLS FOR TREATING DIABETES | CITY OF HOPE (US) | 2026-05-15 | — | — | WO | claimed |
| WO-2026099249-A1 | MODIFIED AND UNMODIFIED PEPTIDYLGLYCINE ALPHA-AMIDATING MONOOXYGENASE (PAM) FOR USE IN SUBJECTS HAVING INCREASED AMYLOID-BETA AND/OR PHOSPHO-TAU-PROTEIN LOAD AND/OR NEUROINFLAMMATION | PAM THERAGNOSTICS GMBH (DE) | 2026-05-15 | — | — | WO | claimed |
| CN-122050814-A | Noninvasive early warning method and device for autoimmune gastritis | 首都医科大学附属北京友谊医院 | 2026-05-15 | — | — | CN | claimed |
| CN-122038300-A | Culture medium and culture method of gastric cancer ascites source organoid | 上海万何圆生物科技有限公司 | 2026-05-15 | — | — | CN | claimed |
| CN-115724949-B | Murine lgG monoclonal antibody and preparation method and application thereof | 郑州伊美诺生物技术有限公司 | 2026-05-15 | — | — | CN | claimed |
| US-20260132380-A1 | Hepatocyte Expansion Methods | KONINKLIJKE NEDERLANDSE AKADEMIE VAN WETENSCHAPPEN (NL) | 2026-05-14 | — | — | US | claimed |
| EP-3016684-B1 | REGULATION OF GLUCOSE METABOLISM USING ANTI-CGRP ANTIBODIES | H LUNDBECK AS (DK) | 2022-02-23 | — | — | EP | claimed |
| CN-114075538-A | Method for constructing in-situ primary endometrial cancer animal model | 四川大学华西医院 | 2022-02-22 | — | — | CN | claimed |
| US-20220048868-A1 | Microcrystalline Diketopiperazine Compositions and Methods | WILMINGTON TRUST, NATIONAL ASSOCIATION, AS COLLATERAL AGENT | 2022-02-17 | — | — | US | claimed |
| EP-3954764-A1 | METHOD FOR CULTURING PRIMARY CELLS OF GASTRIC CANCER AND GALLBLADDER AND BILE DUCT CANCER, AND SUPPORTING REAGENTS | Genex Health Co.,Ltd (CN) | 2022-02-16 | — | — | EP | claimed |
| WO-2022031095-A1 | METHOD FOR CONSTRUCTION OF PANCREATIC CANCER ORGANOID | 연세대학교 산학협력단 | 2022-02-10 | — | — | WO | claimed |
| CN-112608900-B | Method for culturing colorectal cancer cell line through organoid domestication and colorectal cancer cell line | 北京科途医学科技有限公司 | 2022-02-08 | — | — | CN | claimed |
| WO-2022023541-A1 | COMPOSITION COMPRISING A RAPALOG AND A RADIOLABELLED GASTRIN ANALOGUE, IN PARTICULAR FOR USE IN THE TREATMENT AND/OR DIAGNOSIS OF CCKB RECEPTOR POSITIVE CANCER OR TUMORS | PAUL SCHERRER INSTITUT (CH) | 2022-02-03 | — | — | WO | claimed |
| WO-2022023554-A1 | ALPHA RADIOLABELED GASTRIN ANALOGUE AND USE THEREOF IN METHODS OF TREATING CCKB RECEPTOR POSITIVE DISEASE | PAUL SCHERRER INSTITUT (CH) | 2022-02-03 | — | — | WO | claimed |
| WO-2022023539-A1 | GALLIUM-LABELED GASTRIN ANALOGUE AND USE IN A METHOD OF IMAGING CCKB-RECEPTOR-POSITIVE TUMORS OR CANCERS | DEBIOPHARM INTERNATIONAL S.A. (CH) | 2022-02-03 | — | — | WO | claimed |
| US-20220031863-A1 | NANOPARTICLE DELIVERY SYSTEM | MASTER DYNAMIC LIMITED (CN) | 2022-02-03 | — | — | US | claimed |